New Profile of Drug-Resistant Tuberculosis in Russia
eBook - PDF

New Profile of Drug-Resistant Tuberculosis in Russia

A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science

,
  1. 159 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

New Profile of Drug-Resistant Tuberculosis in Russia

A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science

,

About this book

An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world.Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access New Profile of Drug-Resistant Tuberculosis in Russia by in PDF and/or ePUB format. We have over one million books available in our catalogue for you to explore.

Information

Edition
0

Table of contents

  1. FrontMatter
  2. Reviewers
  3. Contents
  4. Tables, Figures, and Boxes
  5. Acronyms
  6. 1 Introduction
  7. 2 A Global Perspective on Drug-Resistant Tuberculosis
  8. 3 Drug-Resistant Tuberculosis in the Russian Federation
  9. 4 Transmission and Infection Control of Drug-Resistant TB
  10. 5 Diagnosis of Drug-Resistant TB
  11. 6 Treatment of Drug-Resistant TB
  12. 7 TB and Drug-Resistant TB in Vulnerable Populations
  13. 8 The Second-Line Drug Supply Chain
  14. 9 The Development of New TB Diagnostics and Drugs
  15. 10 Convergence of Science and Policy to Create a Call for Action
  16. References
  17. Appendix A: Agenda
  18. Appendix B: Summary of a Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Held May 24–25, 2010, Moscow, Russian Federation
  19. Appendix C: Participant Biographies